-transparent.png){kind=logo}
Normal human and psoriatic epidermal phospholipase A2 (PLA2) was inhibited by human recombinant lipocortin I when the substrate was present in a several million-fold molar excess. Inhibition was not total, even at relatively high concentrations of lipocortin I. It is therefore suggested that human epidermis contains two species of PLA2: one that is controlled by lipocortin I and one that is not.
Related Publications
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
January 1990,
Progress in clinical and biological research,
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
September 1993,
The Journal of investigative dermatology,
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
September 1986,
Biochemical and biophysical research communications,
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
April 1989,
FEBS letters,
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
June 1987,
The Journal of biological chemistry,
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
December 2006,
Analytical biochemistry,
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
May 1987,
FEBS letters,
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
December 1979,
Clinical and experimental dermatology,
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
September 1978,
Clinical and experimental dermatology,
P H Cartwright, and
E Ilderton, and
J M Sowden, and
H J Yardley
May 1987,
The Journal of biological chemistry,
